00:57:46 slide 039

JUMP DIRECTLY TO SLIDE Opening Remarks by David Schteingart Introduction of Daniel Federman Talk by Daniel Federman Individual Participant / Participant Perspective Responsible Research - Protect Every Research Participant - What is an HRPPP? - highest ethical standard - accountability etc. - necessary conditions - Refocus protocol review - Informed consent - Risk appropriate monitoring - Compensation for injury and costs Panel Discussion led by Gilbert Omenn The Role of Academic Medical Centers The Societal Compact Clinical Research Trends - Favorable Factors Research America The U.S. should remain a leader in medical research Value of clinical research Good Hospitals Conduct Medical Research and Train Medical Students How likely would you be to participate in a clinical research study? Introduction to Dorene Markel U of M Improvements and Initiatives University Initiative MPRIME Functional Overview Medical School Initiative Panel Discussion - Edward Goldman Case presentation #1 Case presentation #2 Case presentation #3 Case presentation #4 Case Presentation Summaries - Vernon Sondak Human Subjects Protection Compliance with regulations is not enough Human Subjects Protection Compliance with regulations is not enough Human Subjects Protection How are our IRBs doing? Human Subjects Protection The Therapeutic Misconception Human Subjects Protections Are we worried about the right things? Closing Remarks by Gilbert Omenn Closing Remarks by Daniel Federman        synchronize video with current slide